Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
MRK
Merck Company
$89.19
Login to see Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Trading below its fair value
Upgraded on attractively valued
Chart
$84.61 (+5.41%)
$83.7 (+6.56%)
$73.69 (+21.03%)
$108.7 (-17.95%)
MRK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Investors losing confidence
MRK overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
MRK Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MRK Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayMRK Earnings
The TTM reflects 12-month period, providing review of MRK financial performance.
The company financial health has moderately improved over the past year
Financial Score
AZN
85.31
+1.98%
NVS
132.39
+1.08%
PFE
27.37
+1.07%
SNY
50.90
+1.52%
LLY
839.87
+2.44%
What is MRK current stock price?
What are MRK stock strengths?
What risks are associated with MRK stock?
When is MRK next earnings report?
What is MRK market cap and volume?
What is MRK's current Stock IQ?
Should I buy MRK stock right now?
Is MRK a Strong Buy right now?
What does a 'Strong Buy' rating mean for MRK?
What does a 'Strong Sell' rating mean for MRK?
What factors influence MRK's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
MRK
Merck Company
Current Price
$89.19
Stock Insights
Strengths
Earnings are forecast to grow
Trading below its fair value
Upgraded on attractively valued
Linked to MRK
AZN
85.31
+1.98%
NVS
132.39
+1.08%
PFE
27.37
+1.07%
SNY
50.90
+1.52%
LLY
839.87
+2.44%
Login to unlock Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$84.61 (+5.41%)
$83.7 (+6.56%)
$73.69 (+21.03%)
$108.7 (-17.95%)
MRK Analysts Opinion
MRK Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
MRK Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MRK Street view is bullish and have positive views on the near-term outlook
MRK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Investors losing confidence
Average key support and resistance price levels.
Login to displayMRK Earnings
The TTM data reflects the most recent 12-month period, providing overview of MRK financial performance.
MRK Financial Health
The company financial health has moderately improved over the past year
Financial Score
MRK Latest Analysis
Merck & Cos Options: A Look at What the Big Money is Thinking. Financial giants have made a conspicuous ish move on Merck &. Co. Our analysis of options history for Merck &. Co (NYSE:) revealed 23 unusual trades.Delving into the details we found 47% of traders were ish while 30% showed bearish tendencies. Out of all the trades we spotted 11 were puts with a value of $512555 and 12 were calls valued at $590682.Taking into account the Volume and Open Interest on these contracts it appears th
Today
Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati
Today
What Does Wall Street Think About Merck & Co. (MRK)?. Merck &. Co. Inc. (NYSE:MRK) is one of the best medical stocks to buy now. On September 26 Bernstein analyst Courtney Breen maintained a Hold rating on Merck &. Co. Inc. (NYSE:MRK). Similarly Roth MKM also assigned a Hold rating to the stock on September 17 with a $90 price target. In another report released [….]
Today
Is Most-Watched Stock Merck & Co. Inc. (MRK) Worth Betting on Now?. Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus it is worth knowing the facts that could determine the stocks prospects.
Thu Oct 2, 2025
Merck & Co (MRK) Announced Positive Results From Phase 3 HYPERION Trial of WINREVAIR. Merck &. Co. Inc. (NYSE:MRK) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 30 Merck &. Co. Inc. (NYSE:MRK) announced positive results from its Phase 3 HYPERION trial of WINREVAIR in adults recently diagnosed with pulmonary arterial hypertension. The trial included patients classified as functional class 2 or [….]
Thu Oct 2, 2025
MRK Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati
Wed Oct 1, 2025
Merck (MRK) Shares Cross Above 200 DMA. In trading on Wednesday shares of Merck &. Co Inc (Symbol: MRK) crossed above their 200 day moving average of $85.98 changing hands as high as $87.32 per share. Merck &. Co Inc shares are currently trading up about 3.7% on the day. The chart below shows the one year pe
Wed Oct 1, 2025
Tuesday Sector Leaders: Healthcare Utilities. In afternoon trading on Tuesday Healthcare stocks are the best performing sector up 1.3%. Within that group Pfizer Inc (Symbol: PFE) and Merck &. Co Inc (Symbol: MRK) are two large stocks leading the way showing a gain of 5.5% and 5.1% respectively. Among healthcare ETF
Tue Sep 30, 2025
Merck: Initiating Strong Buy On Shift To Qlex SC Injection For Solid Tumors.
Tue Sep 30, 2025
Merck & Co. Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development. Merck &. Co. Inc. (NYSE:MRK) is one of the best conservative stocks to buy now. On September 23 the company confirmed a strategic collaboration with Variational AI to leverage its Enki Platform in designing small-molecule drug candidates. Variational AI is to use a customized version of the Enki Platform trained on Mercks proprietary data to [….]
Tue Sep 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings